Muskoka and area, ON – October 2, 2024 – Muskoka Algonquin Healthcare (MAHC) will convene an important Board of Directors meeting on October 10, 2024, during which an essential vote will occur regarding the Stage 1.3 capital redevelopment plan submission to the Ministry of Health. This decision is a pivotal step in MAHC’s ongoing efforts to enhance healthcare services for Muskoka and area through the establishment of two new acute care hospitals.
The board will consider a motion that underscores the Province of Ontario’s significant investment in local healthcare expansion, the comprehensive analyses and consultations undertaken by MAHC, and the commitment to continued stakeholder engagement.
Importantly, the MAHC capital redevelopment steering committee recommends adding 10 new beds to the Bracebridge site, increasing the total to 46. This recommendation comes as a result of extensive stakeholder engagement, demonstrating that MAHC has listened to community concerns and is responding proactively to anticipated future growth. While it extends beyond the current data corridor, it reflects a commitment to high-quality patient care, preserves existing services, and maintains the integrity of the overall plan.
In a letter signed by 45 physicians from South Muskoka earlier today, they expressed support for the proposed plan to add 10 beds at the Bracebridge site, stating that it will sufficiently meet the care needs of South Muskoka residents. M.P.P. Graydon Smith also endorsed the plan, calling it “a tremendously positive development.” Final approval from the board is needed before the proposal can be submitted to the Ministry of Health.
Board Meeting Details:
- Date: October 10, 2024
- Time: 4:00 PM – 6:00 PM
- Location: Huntsville District Memorial Hospital Boardroom
Agenda Highlights:
- Open Session:
- Welcome and Land Acknowledgement
- Approval of Agenda
- Declaration of Conflict of Interest
- Stage 1.3 Functional Program Review and Discussion
- In-Camera Session:
- Discussion of detailed financial analysis related to the Stage 1.3 submission.
- Open Session:
- Board Vote
The open session will be accessible to the public; however, seating is limited. Attendees must register at least 24 hours in advance. Pre-registration is available at: https://form.mahc.ca/Board-Meeting-Registrations/Board-of-Director-Meeting-Registration.
Following the in-camera session, MAHC will provide an update to the community on the board’s decisions and the next steps in the submission process.
Quotes:
Carla Ladd, Capital Redevelopment Steering Committee Chair and Vice Chair of the Board, stated, “This vote is crucial for the future of healthcare in Muskoka. By moving forward with the Stage 1.3 submission, we are demonstrating our commitment to building a stronger, more adaptable healthcare system that benefits everyone for years to come.”
Board Chair Dave Uffelmann added, “We are proud of the work done to reach this important milestone. The addition of new beds at the Bracebridge site, pending board approval, reflects our dedication to responding to community needs while supporting Muskoka’s growing healthcare demands.”
For more information, please contact:
Bobbie Clark (she/her)
Director, Communications and Stakeholder Relations
Muskoka Algonquin Healthcare
T: 705.789.2311 x 2711
E: bobbie.clark@mahc.ca